Welcome Guest! | login
US ES

MoatRx
Timeline
blog
forum

Activity Stream

MoatRx » Timeline » Timeline Update
MoatRx
@moatrx • 3 weeks ago
Posted a new blog:
US ALZHEIMER'S DISEASE — Competitive Intelligence
Lecanemab slows cognitive decline 27%, donanemab 35%, yet CMS amyloid confirmation and ARIA monitoring gate access for 6.7 million eligible US patients. Two...

Tags

Dislike 0
You must be logged in to post a comment
MoatRx
View All
Followers:
bestcwlinks willybenny01 beejgordy quietsong vigilantcommunications avwanthomas audraking askbarb artisticsflix artisticflix aanderson645 arojo29 anointedhearts annrule rsacd
Recently Rated:
stats
Blogs: 120